This product has been discontinued.
We are offering Casein Kinase II Inhibitor III, TBCA (Cat. No. 218710) as a possible alternative. Please read the alternative product documentation carefully and contact technical service if you need additional information.
A cell-permeable brominated benzimidazolo compound that acts as a potent, high affinity and ATP-competitive inhibitor of CK2 (IC50 = 140 nM for rat liver CK2; Ki = 40 nM). Displays ~1300 fold greater selectivity over CK1 (IC50 > 200 µM) and is superior to CK2 inhibitor, TBB (Cat. No. 218697). Inhibits dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1a) with comparable efficacy and minimally affects the activities of 30 other protein kinases tested. Shown to induce apoptosis in Jurkat T cells at 2.5 µM. A 10 mM (5 mg/1.05 ml) solution of Casein Kinase II Inhibitor, DMAT (Cat. No. 218706), in DMSO is also avialable.
|Synonyms||2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, CK2 Inhibitor II, DMAT|
|References||Pagano, M.A., et al 2004. J. Med. Chem. 47 6239. Pagano, M.A., et al. 2004. Biochem. Biophys. Res. Commun. 321, 1040.|
|Structure formula Image|
|Primary Target IC<sub>50</sub>||140 nM|
|Secondary target||CK2 Ki = 40 nM, CK1 (IC₅₀ > 200 µM)|
|Purity||≥95% by HPLC|
|Safety Information according to GHS|
|Product Usage Statements|
|Packaged under inert gas||Packaged under inert gas|
Casein Kinase II Inhibitor II, DMAT SDS
|Pagano, M.A., et al 2004. J. Med. Chem. 47 6239. Pagano, M.A., et al. 2004. Biochem. Biophys. Res. Commun. 321, 1040.|
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.